Showing results (101-110 of 337) with videos related to

Sort By:
Pageof 34
Precision Clinical Medicine|October 11, 2019
The size of cell-free mitochondrial DNA in blood is inversely correlated with tumor burden in cancer patientsQin An, Youjin Hu, Qingjiao Li, et al.
Urologic Oncology|September 13, 2011
Fine-tuning robot-assisted radical prostatectomy planning with MRIDavid S Finley, Daniel Margolis, Steve S Raman, et al.
The Prostate|February 5, 2019
DHX15 is up-regulated in castration-resistant prostate cancer and required for androgen receptor sensitivity to low DHT concentrationsYadong Xu, Qiong Song, Laura E Pascal, et al.
The Prostate|July 18, 2025
PRMT5:MEP50 Are Mediators of Treatment-Induced Neuroendocrine Differentiation in Prostate CancerHye Seung Nam, Andrew Michael Asberry, Xuehong Deng, et al.
Abdominal Radiology (New York)|July 20, 2017
New prostate cancer prognostic grade group (PGG): Can multiparametric MRI (mpMRI) accurately separate patients with low-, intermediate-, and high-grade cancer?Jamie N Holtz, Rachel Kloss Silverman, Kae Jack Tay, et al.
Endocrine-Related Cancer|November 8, 2018
ATM deficiency promotes progression of CRPC by enhancing Warburg effectLingfan Xu, Enze Ma, Tao Zeng, et al.
Cancer Letters|November 7, 2016
Epidermal growth factor receptor signaling promotes metastatic prostate cancer through microRNA-96-mediated downregulation of the tumor suppressor ETV6Yuan-Chin Tsai, Wei-Yu Chen, Man Kit Siu, et al.
European Journal of Cancer (Oxford, England : 1990)|February 26, 2014
Poor prognosis and advanced clinicopathological features of clear cell renal cell carcinoma (ccRCC) are associated with cytoplasmic subcellular localisation of Hypoxia inducible factor-2αNils Kroeger, David B Seligson, Sabina Signoretti, et al.
Practical Radiation Oncology|June 11, 2015
Multiparametric magnetic resonance imaging for prostate cancer improves Gleason score assessment in favorable risk prostate cancerMitchell Kamrava, Amar U Kishan, Daniel J Margolis, et al.
Cancer Research|December 17, 2010
Prognostic value and function of KLF4 in prostate cancer: RNAa and vector-mediated overexpression identify KLF4 as an inhibitor of tumor cell growth and migrationJi Wang, Robert F Place, Vera Huang, et al.
Pageof 34